Arsil%25252525252525252525252525252525252525252525252525252525252525252520dx

# Arsil-DX (Dextromethorphan Hydrobromide/Chlorpheniramine Maleate) ## Overview Arsil-DX is a combination over-the-counter (OTC) preparation typically containing an antitussive (Dextromethorphan) and a first-generation antihistamine (Chlorpheniramine). It is indicated for the temporary relief of cough and upper respiratory symptoms associated with the common cold, allergies, or bronchitis. ## Primary Indications * Temporary relief of cough due to minor throat and bronchial irritation. * Relief of sneezing, runny nose, and itchy/watery eyes associated with the common cold or hay fever. ## Adult Dosing * **Standard dose:** 10–20 mg (Dextromethorphan) / 2–4 mg (Chlorpheniramine) every 4–6 hours as needed. * **Maximum:** Do not exceed 120 mg of Dextromethorphan or 24 mg of Chlorpheniramine in a 24-hour period. ## Pediatric Dosing * **Children 6–12 years:** 5–10 mg (Dextromethorphan) / 1–2 mg (Chlorpheniramine) every 4–6 hours. Maximum 60 mg Dextromethorphan/12 mg Chlorpheniramine per 24 hours. * **Children <6 years:** Generally **not recommended** without direct physician supervision due to risk of serious side effects and lack of proven efficacy. * *Note: Dosing varies by specific formulation/concentration; always confirm the concentration on the product label.* ## Dose Adjustments * **Renal/Hepatic Impairment:** No standardized guidelines exist; use caution or reduced frequency in severe impairment due to accumulation of metabolites or prolonged half-life of sedating antihistamines. * **Geriatric:** Use with caution. Elderly patients are at higher risk for urinary retention, constipation, confusion, and falls secondary to the anticholinergic effects of Chlorpheniramine. ## Contraindications * Hypersensitivity to any component of the product. * Concomitant use of MAO inhibitors (MAOIs) or within 14 days of discontinuing an MAOI (risk of serotonin syndrome). * Presence of narrow-angle glaucoma, stenosing peptic ulcer, or symptomatic prostatic hypertrophy (due to anticholinergic effects). ## Adverse Effects * **Anticholinergic:** Dry mouth, constipation, urinary retention, blurred vision. * **CNS:** Drowsiness, dizziness, sedation, paradoxical excitation in children. * **Dextromethorphan:** Rare reports of nausea, vomiting, and high-dose abuse potential. ## Key Drug Interactions * **MAOIs:** Potential for fatal serotonin syndrome or hypertensive crisis. * **CNS Depressants:** Alcohol, opioids, and sedatives may result in potentiation of sedation/respiratory depression. * **CYP2D6 Inhibitors:** (e.g., Fluoxetine, Paroxetine) May increase serum concentrations of Dextromethorphan. ## Monitoring * Monitor for symptomatic improvement. * Assess for excessive sedation or anticholinergic toxidrome (confusion, dry skin, tachycardia, urinary retention), particularly in geriatric or pediatric populations. ## Clinical Pearls * **Self-Care Limitation:** Advise patients that these products should not be used for chronic cough (e.g., asthma, emphysema) or cough productive of excessive phlegm. Consult a provider if symptoms persist beyond 7 days or are accompanied by a high fever. * **First-line caution:** First-generation antihistamines like Chlorpheniramine are on the Beers Criteria list as "potentially inappropriate" for older adults due to substantial anticholinergic burden. * **Avoid "Double-Dosing":** Patients often inadvertently overdose by taking multiple cold preparations containing the same active ingredients. Always review the "Drug Facts" label for shared ingredients. *** **Educational Disclaimer:** This information is for educational purposes only. Drug formulations vary by manufacturer and region; always verify the exact concentration, current prescribing information, and local clinical protocols before administering or recommending this medication. Seek guidance from a licensed pharmacist or physician for specific clinical decisions.